NewsVenture Capital Trustero Raises $10.35 Million Series A Funding PALO ALTO — Trustero, a Silicon Valley-based provider of AI-powered Security and Compliance, has closed… EditorNovember 24, 2024
FacebookNewsVenture Capital VISO Trust Secures $7 Million SAN FRANCISCO — VISO TRUST, a provider of AI-powered third-party risk management (TPRM), announced the closing… EditorNovember 22, 2024
FacebookNewsVenture Capital CUPERTINO and MUMBAI, India — OneCell Diagnostics, a genomics-based precision oncology company, has raised $16 million in… EditorNovember 22, 2024
NewsVenture Capital DCM Ventures to Spin Off Seed Division MENLO PARK — DCM Ventures, a global early-stage venture capital firm headquartered in Silicon Valley,… EditorNovember 20, 2024
NewsVenture Capital Cresta Closes $125 Million Series D PALO ALTO — Cresta, an end-to-end generative AI platform for contact centers, has announced the closing of… EditorNovember 20, 2024
NewsVenture Capital Anello Photonics Reveals Series B Funding SANTA CLARA — ANELLO Photonics, creator of the Silicon Photonic Optical Gyroscope (SiPhOG), announced the… EditorNovember 19, 2024
NewsVenture Capital Shiru Discovers $16 Million Round BERKELEY — Shiru, a pioneer in AI-powered ingredient discovery, has secured a $16 million investment round as it… EditorNovember 14, 2024
NewsVenture Capital Medeloop Reels In $15.5 Million MENLO PARK — Medeloop, a medical research platform, has closed a $15.5 million Series A… EditorNovember 14, 2024
NewsVenture Capital Airbus Ventures Invests in Bifrost AI MENLO PARK — Airbus Ventures has made an investment in San Francisco-based Bifrost AI, a… EditorNovember 12, 2024
NewsVenture Capital PuppyGraph Lands $5 Million Seed Funding SAN FRANCISCO — PuppyGraph, the first and only graph query engine, announced its $5 million… EditorNovember 12, 2024
NewsVenture Capital General Prognostics Receives Funding From NEC X PALO ALTO — NEC X, the Silicon Valley venture studio backed by NEC’s portfolio of… EditorNovember 12, 2024
NewsVenture Capital Evommune Lands $115 Million Series C PALO ALTO — Evommune, Inc., a clinical-stage biotechnology company discovering and developing new ways to… EditorNovember 7, 2024